The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final survival follow-up and translational associations using interval indirect immunization with oregovomab (O) and poly ICLC in patients (pts) with recurrent platinum-resistant ovarian cancer (PROC).
 
Robert W. Holloway
Consulting or Advisory Role - Abbvie; Clovis Oncology
Speakers' Bureau - AstraZeneca; Bard/Davol; Clovis Oncology; Tesaro
 
Sarah Madhu Temkin
Consulting or Advisory Role - Cancer Experts Now; Cancer Experts Now; Clovis Oncology
 
Sarah W. Gordon
No Relationships to Disclose
 
Sunil Gupta
Employment - Agenus; OncoQuest Pharmaceuticals
Leadership - Agenus
Stock and Other Ownership Interests - Agenus; Sanofi
Patents, Royalties, Other Intellectual Property - I received 3 patents on method of use for cabazitaxel (Jevtana( for patients with mCRPC who have been previously treated with docetaxel while employed with Sanofi Inc. The rights to the patients were transferred to Sanofi and I receive no compensation or
Travel, Accommodations, Expenses - Agenus
 
Christopher F. Nicodemus
Stock and Other Ownership Interests - Pfizer; Quest PharmaTech; United Therapeutics
Consulting or Advisory Role - Hemispherx Biopharma; OncoQuest
Patents, Royalties, Other Intellectual Property - OncoQuest
Travel, Accommodations, Expenses - OncoQuest
 
Madi Madiyalakan
Employment - OncoQuest
Leadership - Quest PharmaTech
Stock and Other Ownership Interests - OncoQuest; Quest PharmaTech
 
William P. McGuire
No Relationships to Disclose